CTRL THERAPEUTICS USA, INC.

Profile

Company Names

CTRL THERAPEUTICS USA, INC.

Addresses

655 SHERIDAN RD, GLENCOE, IL 60022

Phone Numbers

415-283-5794

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2022

State Incorporated:

DELAWARE

Total Amount Raised:

$16,638,892.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-09-19 
$9,135,991.00 
$9,999,998.00 
$864,007.00 
Equity 
1
2022-10-12 
$7,502,901.00 
$10,617,815.00 
$3,114,914.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
KALOS 
DIRECTOR
IMV INC.   |  CTRL THERAPEUTICS USA, INC.
SHANA 
 
KELLEY 
EXECUTIVE OFFICER, DIRECTOR
CTRL THERAPEUTICS USA, INC.
DAVID 
 
O-NEILL 
DIRECTOR
FANTASY SPORTS VENTURES INC   |  APIMETRICS INC.   |  LIONHEART CIDER LLC   |  SABER NORTHGATE 9 HOLDINGS LLC   |  SABER NORTHGATE 5 HOLDINGS LLC   |  SABER NORTHGATE 4 HOLDINGS LLC   |  MCCORD DEVELOPMENT REIT, LLC   |  BREIT BAKERS MEZZ 2 LLC   |  WINSTON US REIT, LP   |  BRE BLUEFIN REIT LLC   |  CTRL THERAPEUTICS USA, INC.   |  APICONTEXT, INC.
DERRELL 
 
PORTER 
EXECUTIVE OFFICER, DIRECTOR
ALGAEVENTURE SYSTEMS, INC.   |  BIOSORTIA PHARMACEUTICALS, INC.   |  CTRL THERAPEUTICS USA, INC.
COLLIN 
 
TODD 
DIRECTOR
CTRL THERAPEUTICS USA, INC.
ELENA 
 
VIBOCH 
DIRECTOR
PEAR THERAPEUTICS, INC.   |  VARIANT BIO, INC.   |  CTRL THERAPEUTICS USA, INC.   |  MEDELOOP, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-09-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-09-19 
2022-10-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#